ArticleJACC. Case reports2025
Contrast-Linked Pseudomonas Outbreak in a Cardiac Catheterization Laboratory: Case Series and Quality-Improvement Response.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfection control breaches in cardiac catheterization laboratories are rare but may lead to severe consequences. Despite being a high-volume center and an award-winning participant in the national cardiovascular data registry Chest Pain MI registry, Tabba Heart Institute experienced a cluster of Pseudomonas aeruginosa infections after coronary procedures. PROJECT RATIONALE: The outbreak posed significant risks to patient safety and institutional benchmarks, prompting an urgent investigation. PROJECT SUMMARY: Between December 2024 and January 2025, 5 patients developed postprocedural complications, 3 of whom had culture-proven P. aeruginosa bloodstream infections, including one fatality. A multidisciplinary team initiated a root cause analysis. Initial infection-control measures failed to prevent further cases. Expanded microbiological testing identified contaminated contrast media as the source. Withdrawal of the implicated product halted new infections. This investigation underscores the importance of stringent surveillance, supply chain oversight, and product sterility verification. TAKE-HOME MESSAGES: Even sealed consumables can harbor life-threatening pathogens. Proactive sterility validation and vendor oversight are essential in high-risk procedural environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.